New SEC Form D filing

Unravel Biosciences, Inc., 2026-08-24

A new SEC Form D private-offering notice from Medford, MA, a $4,500,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Unravel Biosciences, Inc. site↗ Verified via SEC Form D

Biotech developing AI driven computational drug discovery and repurposing therapeutics for complex disorders including rare diseases

Filed 2026-08-24Filed to raise $4,500,000First money in 2026-08-07Raised so far $4,100,000HQ (as filed) Medford, MASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified unravel.bio↗Named in the filing 3 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source